A detailed history of Warren Averett Asset Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 5,351 shares of EW stock, worth $400,308. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,351
Previous 5,238 2.16%
Holding current value
$400,308
Previous $483,000 26.92%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $6,746 - $10,597
113 Added 2.16%
5,351 $353,000
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $2,023 - $2,263
24 Added 0.46%
5,238 $483,000
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $134,126 - $176,690
1,849 Added 54.95%
5,214 $498,000
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $15,427 - $19,440
-250 Reduced 6.92%
3,365 $256,000
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $207 - $280
3 Added 0.08%
3,615 $250,000
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $17,584 - $20,375
216 Added 6.36%
3,612 $340,000
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $18,565 - $21,127
250 Added 7.95%
3,396 $280,000
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $7,717 - $9,880
113 Added 3.73%
3,146 $234,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $26,028 - $33,903
316 Added 11.63%
3,033 $251,000
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $80,185 - $118,906
927 Added 51.79%
2,717 $259,000
Q1 2022

May 17, 2022

BUY
$101.96 - $128.34 $182,508 - $229,728
1,790 New
1,790 $210,000
Q4 2021

Feb 15, 2022

SELL
$106.37 - $130.68 $307,834 - $378,187
-2,894 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $45,794 - $54,623
445 Added 18.17%
2,894 $331,000
Q2 2021

Aug 17, 2021

BUY
$83.84 - $104.76 $205,324 - $256,557
2,449 New
2,449 $277,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Warren Averett Asset Management, LLC Portfolio

Follow Warren Averett Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warren Averett Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warren Averett Asset Management, LLC with notifications on news.